He is a senior staff specialist in tissue pathology and diagnostic oncology at Royal Prince Alfred Hospital,[4][5] co-medical director at the Melanoma Institute Australia,[6] and Conjoint professor at the University of Sydney.
Scolyer provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more than 2000 cases for opinion from Australasia and beyond annually.
[1] He underwent combination immunotherapy before surgical excision, a sequence Scolyer and his colleagues have applied successfully for melanoma, but is non-standard for brain cancer due to concerns about toxicity, whether drugs will reach the brain, and speed of tumour development.
As at eighteen months after surgery, Scolyer's cancer has not returned, a promising result with potentially broader implications, though oncologists warn that it is too early to judge effectiveness versus standard protocols.
[11] He was appointed an Officer of the Order of Australia for "distinguished service to medicine, particularly in the field of melanoma and skin cancer, and to national and international professional organisations" in the 2021 Queen's Birthday Honours.